3,4-dihydroxyphenylacetic acid has been researched along with 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costentin, J; Leroux-Nicollet, I; Naudon, L | 1 |
Bonnet, JJ; Costentin, J; Vaugeois, JM | 1 |
Hurd, YL; Ungerstedt, U | 1 |
Muscholl, E; Racké, K | 1 |
Bredeloux, P; Costentin, J; Dubuc, I | 1 |
Aguirre, N; Barros-Miñones, L; Beitia, G; Goñi-Allo, B; Puerta, E; Suquia, V | 1 |
6 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine
Article | Year |
---|---|
Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Autoradiography; Binding Sites; Biological Transport; Choline; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Homovanillic Acid; Kainic Acid; Male; Membrane Proteins; Microinjections; Nerve Tissue Proteins; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Synaptosomes; Tetrabenazine; Tritium | 1992 |
Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Antagonists; Homovanillic Acid; Levodopa; Male; Mice; Motor Activity; Piperazines; Reserpine | 1990 |
In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Caudate Nucleus; Dialysis; Dopamine; Dopamine Agents; Homovanillic Acid; Indans; Male; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Putamen; Rats; Rats, Inbred Strains | 1989 |
Release of endogenous 3,4-dihydroxyphenylethylamine and its metabolites from the isolated neurointermediate lobe of the rat pituitary gland. Effects of electrical stimulation and of inhibition of monoamine oxidase and reuptake.
Topics: 3-Methoxy-4-hydroxyphenylethanol; 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Electric Stimulation; Female; Homovanillic Acid; Kinetics; Monoamine Oxidase Inhibitors; Pargyline; Piperazines; Pituitary Gland, Posterior; Rats | 1986 |
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Bupropion; Corpus Striatum; Dextroamphetamine; Dopamine; Epilepsy, Generalized; Homovanillic Acid; Male; Mice; Motor Activity; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Transmission | 2007 |
Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aconitate Hydratase; alpha-Methyltyrosine; Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Electron Transport Complex I; Gene Expression Regulation; Hallucinogens; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Tyrosine 3-Monooxygenase | 2015 |